Healthmark Industries announced the promotion of Mary Ann Drosnock, MS, CIC, CFER, RM (NRCM), FAPIC to Director of Clinical Education.
“Mary Ann has been a key part of our success and we are thrilled to promote her to this important position,” says Vice President Ralph Basile. “I am honored to accept this position and together with my team of clinical educators, I look forward to continuing to promote proper processing of medical devices to prevent infections,” says Mary Ann. Drosnock joined Healthmark in 2015 as the Clinical Education Manager for Endoscopy. Before joining Heathmark, Mary Ann was responsible for management of the Infection Control Program and Device Reprocessing Functions for Olympus America, including Canada and Latin America. In this role, she had responsibility for the development of position statements and policies regarding device compatibility, and health and safety information related to device utilization and reprocessing.
Earlier in her career, Mary Ann worked for 9 years in the pharmaceutical industry in a supervisory capacity as a microbiologist in both quality control and research and development. Immediately following this role, she moved on to be an adjunct professor of Microbiology at a local college.
In 1999 Mary Ann received a B.S. in Biology from Albright College in Reading, PA, and in 2006 she received a Master of Science degree in Medical Device & Pharmaceutical Quality Assurance and Regulatory Affairs from Temple University in Philadelphia, PA. She has also obtained certifications in both Drug Development and Pharmaceutical Science from Temple University. In 2011, she received her certification in Infection Control through APIC and the Certification Board of Infection Control (CBIC). In 2012, Mary Ann received her certification as a Flexible Endoscope Reprocessor (CFER) through the Certification Board of Sterile Processing (CBSPD). Additionally, as of 2013 she attained the status of Nationally Certified Registered Microbiologist (RM [NCRM]) through the American Society for Microbiology (ASM). Also, in 2016 she was appointed a Fellow of the American Society for Professionals in Infection Prevention and Control (APIC). Mary Ann is an active member of AAMI’s Sterilization Standards Committee, including the co-chair of WG84, the work group responsible for the development of ST91, endoscope reprocessing document.
Editor's note: this press release originally appeared on Healthmark's website.
Visit www.hmark.com or call 800-521-6224 for more information.
About Healthmark Industries Co., Inc.
Since 1969, Healthmark Industries Company, Inc. has developed and marketed innovative solutions to aid healthcare facilities in their delivery of surgical instruments and other lifesaving medical devices to patients. Healthmark Industries mission is to continue to innovate, continue to support and continue to serve the healthcare provider industry and support services that make it possible to deliver quality healthcare. Visit www.hmark.com for more information.